がん治療におけるナノロボット工学の翻訳:展望、進歩、そして持続的な障壁
Ursula Abu Nahla1, Muhammad Suleman2, Inshrah Khan2
1Faculty of Medicine, Hebron University, Hebron, Palestine.
Annals of medicine and surgery (2012)
|January 7, 2026
まとめ
ナノロボットのがん治療は、精密な薬物送達の可能性を示していますが、重大な障害に直面しています。これらの高度な技術を患者ケアに移行させるためには、臨床的検証、規制、製造における課題を克服することが不可欠です。
科学分野:
- 腫瘍学
- バイオテクノロジー
- ナノテクノロジー
背景:
- ナノロボット技術は、標的化された薬物送達や毒性の低減を含む、精密ながん治療の可能性を提供します。
- DNAオリガミや磁気ナビゲーションシステムは前臨床段階で有望視されており、理論的には従来の化学療法よりも優れています。
- しかし、ナノロボットを実験室の研究から臨床応用へと進める上で、かなりの翻訳上の障壁が存在します。
主な方法:
- ナノロボットのがん治療に関する既存の前臨床エビデンスと理論的枠組みのレビュー。
- 規制、製造、安全性、およびアウトカム測定の限界の特定。
- 臨床的検証と学際的協力の必要性の分析。
結論:
- 成功する翻訳には、厳密な評価を通じて規制、製造、および安全性の懸念に対処する必要があります。
- 患者登録簿、検証された指標、体系的なレビュー、および包括的な安全プロトコルの確立が不可欠です。
- 学際的な協力は、ナノロボット腫瘍学を前臨床の可能性から臨床的現実に進めるために不可欠です。
さらに関連する動画
07:54Surface-enhanced Resonance Raman Scattering Nanoprobe Ratiometry for Detecting Microscopic Ovarian Cancer via Folate Receptor Targeting
Published on: March 25, 2019
8.6K
09:02Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment
Published on: September 27, 2024
3.0K
関連する概念動画
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K
Microorganisms in Medicine and Therapeutics
928
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
928
Tumor Progression
7.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.2K
The Nucleolus
10.2K
The nucleolus is the most prominent substructure of the nucleus. When it was first discovered, it was considered to be an isolated organelle that forms fibrils and granules. In 1931, the relationship between the nucleolus and chromosomes was first described by Heitz. He observed that the appearance and size of nucleolus varies depending on the stage of the cell cycle. He also noticed constricted regions on different chromosomes clustered together at definite cell cycle stages. These regions,...
10.2K
